| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.36▲ | 3.36▲ | 3.36▲ | 3.24▲ | 3.64▼ |
| MA10 | 3.35▲ | 3.31▲ | 3.28▲ | 3.36▼ | 3.92▼ |
| MA20 | 3.35▲ | 3.14▲ | 3.18▲ | 3.62▼ | 4.37▼ |
| MA50 | 3.20▲ | 3.35▲ | 3.45▼ | 3.98▼ | 3.04▲ |
| MA100 | 3.36▲ | 3.60▼ | 3.73▼ | 4.37▼ | 2.66▲ |
| MA200 | 3.65▼ | 3.86▼ | 3.95▼ | 3.34▼ | 2.13▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.048▲ | 0.050▲ | -0.022▼ | -0.215▼ |
| RSI | 53.926▲ | 55.694▲ | 52.669▲ | 41.067▼ | 42.543▼ |
| STOCH | 51.584 | 73.671 | 79.510 | 29.478 | 25.953 |
| WILL %R | -47.717 | -20.968▲ | -20.968▲ | -59.918 | -77.725▼ |
| CCI | 40.778 | 61.942 | 63.125 | -46.084 | -199.187▼ |
|
Friday, January 23, 2026 12:18 PM
LIXTE Biotechnology (NASDAQ: LIXT) is a clinical-stage pharmaceutical company leading efforts in addressing some of the pressing challenges in cancer treatment. Instead of developing standalone ...
|
|
Friday, January 23, 2026 09:24 AM
The company is building a differentiated oncology pipeline supported by experienced leadership and scientific expertise ...
|
|
Wednesday, January 21, 2026 02:10 PM
LIXTE Biotechnology Holdings (NASDAQ: LIXT) is sponsoring the inaugural Good Health: Mind, Body & Soul Summit, an invitation-only event inspired by the music, legacy, and lived experiences of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/01/26 | 3.30 | 3.50 | 3.2933 | 3.33 | 61,084 |
| 22/01/26 | 3.21 | 3.51 | 3.21 | 3.35 | 29,330 |
| 21/01/26 | 3.03 | 3.43 | 2.86 | 3.16 | 133,437 |
| 20/01/26 | 3.25 | 3.33 | 2.90 | 3.04 | 109,193 |
| 16/01/26 | 3.41 | 3.64 | 3.32 | 3.32 | 140,410 |
| 15/01/26 | 3.61 | 3.64 | 3.33 | 3.41 | 61,535 |
| 14/01/26 | 3.308 | 3.66 | 3.2647 | 3.575 | 59,759 |
| 13/01/26 | 3.44 | 3.55 | 3.28 | 3.34 | 73,995 |
| 12/01/26 | 3.61 | 3.64 | 3.40 | 3.40 | 66,768 |
| 09/01/26 | 3.73 | 3.80 | 3.61 | 3.65 | 75,641 |
|
|
||||
|
|
||||
|
|